GABICA CR 82.5MG TAB

Gabica CR 82.5mg is a sustained-release formulation of gabapentin designed for extended therapeutic coverage. This controlled-release tablet delivers consistent medication levels throughout the day, making it suitable for patients requiring long-term neuropathic pain management or seizure control. The 82.5mg dosage provides precise therapeutic dosing for individualized treatment plans. Ideal for patients seeking reduced dosing frequency while maintaining steady-state drug concentrations.